TVGN 920

N/A

Report date: 2024/08/20 10:02:13

Base Information

Drug NameTVGN 920
Drug Alias NameTVGN-920TVGN 920
ClassificationCell and gene therapy > Cell therapy > Immune system cell therapy > Lymphocytes therapy > T-lymphocyte cell therapy
Mechanisms of ActionCytotoxic T lymphocytes replacements
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTevogen Bio Inc
China Registration ClassN/A

Develop Information

Active CompaniesTevogen Bio Inc
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A